Medicare Enrolled
Dr. Pushpendu Banerjee, M.D.
Medical Oncology · La Jolla, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Banerjee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banerjee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Banerjee
Dr. Pushpendu Banerjee is a medical oncology specialist in La Jolla, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Banerjee performed 99,278 Medicare services across 2,400 unique beneficiaries.
Between the years covered by Open Payments, Dr. Banerjee received a total of $35,466 from 78 pharmaceutical and/or device companies across 452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Banerjee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in CA
$35,466 industry payments
Medicare Practice Summary
Medicare Utilization ↗99,278
Medicare services
Top 6% in CA for medical oncology
2,400
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,964 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
39,750 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
29,107 | $2 | $12 |
| Denosumab injection (Prolia/Xgeva) | 11,160 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 9,620 | $1 | $11 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,105 | $0 | $8 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
838 | $8 | $11 |
| Anti-nausea injection (Aloxi/palonosetron) | 660 | $1 | $10 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
618 | $2 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
569 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
568 | $10 | $27 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
509 | $70 | $286 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $101 | $418 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
463 | $12 | $40 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
352 | $26 | $87 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
308 | $118 | $400 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
233 | $57 | $197 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
177 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
169 | $149 | $558 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
132 | $1 | $9 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
121 | $25 | $84 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
101 | $59 | $194 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
95 | $29 | $90 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
92 | $65 | $188 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
84 | $14 | $47 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
79 | $66 | $222 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
68 | $16 | $42 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
63 | $18 | $58 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
62 | $13 | $35 |
| Iron level test | 62 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
62 | $9 | $22 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $98 | $252 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
52 | $1 | $10 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
48 | $19 | $48 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
43 | $9 | $24 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
43 | $6 | $16 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $143 | $521 |
| New patient office visit, complex (60-74 min) | 39 | $186 | $594 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
36 | $41 | $95 |
| PSA test (prostate cancer screening) | 32 | $18 | $46 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
32 | $84 | $306 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $39 | $174 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
22 | $15 | $38 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $281 | $898 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
20 | $4 | $12 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $136 | $450 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $54 | $248 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
15 | $1,467 | $4,921 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.1% high complexity
54.7% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,466
Total received (2018-2024)
Avg $5,067/year across 7 years
Top 23% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
452
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,425 (51.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,556 (29.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,486 (18.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,238
2023
$2,272
2022
$965
2021
$747
2020
$1,748
2019
$16,146
2018
$11,349
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$335
Astellas Pharma US Inc
$243
Celgene Corporation
$155
PFIZER INC.
$135
Novartis Pharmaceuticals Corporation
$133
EMD Serono, Inc.
$122
AstraZeneca Pharmaceuticals LP
$114
E.R. Squibb & Sons, L.L.C.
$109
GENZYME CORPORATION
$100
Verity Pharmaceuticals Inc.
$82
Daiichi Sankyo Inc.
$77
BeiGene USA, Inc.
$75
Lilly USA, LLC
$70
Bayer Healthcare Pharmaceuticals Inc.
$54
Janssen Biotech, Inc.
$44
TerSera Therapeutics LLC
$39
Dendreon Pharmaceuticals LLC
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
Merck Sharp & Dohme LLC
$32
Exelixis Inc.
$32
Ipsen Biopharmaceuticals, Inc
$30
Regeneron Healthcare Solutions, Inc.
$28
Blueprint Medicines Corporation
$27
TAIHO ONCOLOGY, INC.
$27
Pharmacosmos Therapeutics Inc.
$25
ABBVIE INC.
$24
ARRAY BIOPHARMA INC
$23
Fennec Pharmaceuticals, Inc.
$18
Agios Pharmaceuticals, Inc.
$17
Top 3 companies account for 32.7% of 2024 payments
All-time payments by company (2018-2024) ›
AMAG Pharmaceuticals, Inc.
$10,753
Mylan Institutional Inc.
$6,150
Heron Therapeutics, Inc.
$3,030
TESARO, Inc.
$2,338
Athenex Pharmaceutical Division, LLC
$1,250
Puma Biotechnology, Inc.
$1,150
E.R. Squibb & Sons, L.L.C.
$844
Celgene Corporation
$621
Novartis Pharmaceuticals Corporation
$599
Ipsen Biopharmaceuticals, Inc
$573
Cardinal Health 108, LLC
$475
PFIZER INC.
$460
AstraZeneca Pharmaceuticals LP
$459
Janssen Biotech, Inc.
$448
GENZYME CORPORATION
$448
Amgen Inc.
$402
Merck Sharp & Dohme Corporation
$402
Foundation Medicine, Inc.
$353
Alexion Pharmaceuticals, Inc.
$350
Pharmacyclics LLC, An AbbVie Company
$329
Astellas Pharma US Inc
$322
Blueprint Medicines Corporation
$214
Boehringer Ingelheim Pharmaceuticals, Inc.
$203
EMD Serono, Inc.
$183
Daiichi Sankyo Inc.
$183
BeiGene USA, Inc.
$173
Genmab U.S., Inc.
$150
Lilly USA, LLC
$140
Bayer Healthcare Pharmaceuticals Inc.
$136
Gilead Sciences, Inc.
$130
Exelixis Inc.
$118
Merck Sharp & Dohme LLC
$117
SERVIER PHARMACEUTICALS LLC
$113
MENARINI SILICON BIOSYSTEMS, INC.
$112
Teva Pharmaceuticals USA, Inc.
$109
Verity Pharmaceuticals Inc.
$108
Regeneron Healthcare Solutions, Inc.
$105
Takeda Pharmaceuticals U.S.A., Inc.
$102
AbbVie, Inc.
$86
Incyte Corporation
$82
Immunocore Limited
$78
Pharmacyclics LLC, an AbbVie Company
$73
Spectrum Pharmaceuticals Inc.
$61
TAIHO ONCOLOGY, INC.
$61
Bayer HealthCare Pharmaceuticals Inc.
$55
GlaxoSmithKline, LLC.
$50
ABBVIE INC.
$44
EISAI INC.
$43
EUSA Pharma (US) LLC
$41
TerSera Therapeutics LLC
$39
Mirati Therapeutics, Inc.
$39
Janssen Scientific Affairs, LLC
$38
Dendreon Pharmaceuticals LLC
$35
Novocure Inc.
$35
Taiho Oncology, Inc.
$33
Pharmacosmos Therapeutics Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
Genentech USA, Inc.
$24
SOBI, INC
$24
Coherus Biosciences Inc.
$24
Kite Pharma, Inc.
$24
ARRAY BIOPHARMA INC
$23
ACCORD HEALTHCARE, INC.
$23
Karyopharm Therapeutics Inc.
$22
Servier Pharmaceuticals LLC
$20
PUMA BIOTECHNOLOGY, INC.
$20
Fresenius Kabi USA, LLC
$18
Fennec Pharmaceuticals, Inc.
$18
Epizyme, Inc.,
$17
Agios Pharmaceuticals, Inc.
$17
AbbVie Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$16
Seattle Genetics, Inc.
$15
Secura Bio, Inc.
$14
Sirtex Medical Inc
$14
Ferring Pharmaceuticals Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Athena Bioscience, LLC
$6
Top 3 companies account for 56.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Aliqopa · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CINVANTI · CREON · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ERLEADA · EVENITY · Enhertu · FERAHEME · FIRMAGON · FOUNDATIONACT · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAVRETO · GILOTRIF · GRANIX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · Ogivri · Oncology · Onivyde · Oral Paclitaxel · PADCEV · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · QDOLO · REBLOZYL · RYDAPT · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stimufend · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · Tazverik · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · YERVOY · ZEJULA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Medical oncologists within 10 mi
22
Per 100K population
0.7
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Banerjee is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with speaking/promotional industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Banerjee experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Banerjee performed 39,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banerjee receive payments from pharmaceutical companies?
Yes. Dr. Banerjee received a total of $35,466 from 78 companies across 452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banerjee's costs compare to other medical oncologists in La Jolla?
Dr. Banerjee's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banerjee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in La Jolla
Browse medical oncologists in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
AMAG Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AMAG Pharmaceuticals, Inc.
By company
Mylan Institutional Inc. Payments to Doctors
See all physicians who received payments from Mylan Institutional Inc.
By company
Heron Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Heron Therapeutics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology